Advertisement

Decreased left atrial global longitudinal strain predicts the risk of atrial fibrillation recurrence after cryoablation in paroxysmal atrial fibrillation

  • Hasan Koca
  • Abdullah Orhan Demirtas
  • Onur Kaypaklı
  • Yahya Kemal Icen
  • Durmus Yıldıray Sahin
  • Fadime Koca
  • Zikret Koseoglu
  • Ahmet Oytun Baykan
  • Emel Celiker Guler
  • Derya Demirtas
  • Mevlut KocEmail author
Article
  • 42 Downloads

Abstract

Purpose

We aimed to investigate the association of atrial fibrillation (AF) recurrence with left atrial (LA) strain in nonvalvular paroxysmal AF patients after cryoablation.

Methods

We included 190 patients who underwent successful cryoablation due to paroxysmal AF. In addition to classical echocardiographic data, LA apical 2-chamber (A2C) strain, LA apical 4-chamber (A4C) strain, and LA global longitudinal strain (LA-GLS) values were calculated by speckle tracking echocardiography. Forty-eight-hour Holter monitoring was performed to all patients no later than 6 months after ablation.

Results

AF recurrence was detected in 42 patients (22.1%). End-systolic diameter, LA end-systolic diameter, LA-volume, LA-volume index, interatrial septum thickness, coronary sinus diameter, epicardial fat thickness (EFT), and septal E/Eˋ ratio were significantly higher, LV-EF, IVRT, septal S and Aˋ wave, lateral S wave, LA-A2C strain, LA-A4C strain, and LA-GLS were significantly lower in patients with AF recurrence. LA-GLS, LA-volume index, and EFT were found to be independent parameters for predicting AF recurrence.

Conclusions

LA-GLS and LAVI should be included in routine evaluations to determine long-term AF recurrence preoperatively.

Keywords

Paroxysmal atrial fibrillation Cryoablation Left atrial global longitudinal strain 

Notes

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Compliance with ethical standards

The study was approved by the institutional ethics committee and complied with the principles of the Declaration of Helsinki.

Conflict of interest

The authors declare they have no conflict of interest.

References

  1. 1.
    Anne W, Willems R, Roskams T, et al. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res. 2005;67:655–66.CrossRefGoogle Scholar
  2. 2.
    Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112:1142–7.CrossRefGoogle Scholar
  3. 3.
    Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34:2746–51.CrossRefGoogle Scholar
  4. 4.
    Sönmez O, Ertem FU, Vatankulu MA, Erdogan E, Tasal A, Kucukbuzcu S, et al. Novel fibro-inflammation markers in assessing left atrial remodeling in nonvalvular atrial fibrillation. Med Sci Monit. 2014;20:463–70.CrossRefGoogle Scholar
  5. 5.
    Okar S, Kaypakli O, Şahin DY, Koç M. Fibrosis marker soluble ST2 predicts atrial fibrillation recurrence after cryoballoon catheter ablation of nonvalvular paroxysmal atrial fibrillation. Korean Circ J. 2018;48:920–9.CrossRefGoogle Scholar
  6. 6.
    Kaypakli O, Koca H, Şahin DY, Okar S, Karataş F, Koç M. Association of P wave duration index with atrial fibrillation recurrence after cryoballoon catheter ablation. J Electrocardiol. 2018;51:182–7.CrossRefGoogle Scholar
  7. 7.
    Yasuda R, Murata M, Roberts R, Tokuda H, Minakata Y, Suzuki K, et al. Left atrial strain is a powerful predictor of atrial fibrillation recurrence after catheter ablation: study of a heterogeneous population with sinus rhythm or atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2015;16:1008–14.Google Scholar
  8. 8.
    Sarvari SI, Haugaa KH, Stokke TM, Ansari HZ, Leren IS, Hegbom F, et al. Strain echocardiographic assessment of left atrial function predicts recurrence of atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2016;17:660–7.CrossRefGoogle Scholar
  9. 9.
    Montserrat S, Gabrielli L, Bijnens B, Borràs R, Berruezo A, Poyatos S, et al. Left atrial deformation predicts success of first and second percutaneous atrial fibrillation ablation. Heart Rhythm. 2015;12:11–8.CrossRefGoogle Scholar
  10. 10.
    Hwang HJ, Choi EY, Rhee SJ, Joung B, Lee BH, Lee SH, et al. Left atrial strain as predictor of successful outcomes in catheter ablation for atrial fibrillation: a two-dimensional myocardial imaging study. J Interv Card Electrophysiol. 2009;26:127–32.CrossRefGoogle Scholar
  11. 11.
    Spethmann S, Stüer K, Diaz I, Althoff T, Hewing B, Baumann G, et al. Left atrial mechanics predict the success of pulmonary vein isolation in patients with atrial fibrillation. J Interv Card Electrophysiol. 2014;40:53–62.CrossRefGoogle Scholar
  12. 12.
    Morris DA, Parwani A, Huemer M, Wutzler A, Bekfani T, Attanasio P, et al. Clinical significance of the assessment of the systolic and diastolic myocardial function of the left atrium in patients with paroxysmal atrial fibrillation and low CHADS(2) index treated with catheter ablation therapy. Am J Cardiol. 2013;111:1002–11.CrossRefGoogle Scholar
  13. 13.
    Mirza M, Caracciolo G, Khan U, Mori N, Saha SK, Srivathsan K, et al. Left atrial reservoir function predicts atrial fibrillation recurrence after catheter ablation: a two-dimensional speckle strain study. J Interv Card Electrophysiol. 2011;31:197–206.CrossRefGoogle Scholar
  14. 14.
    Lim HE, Na JO, Im SI, Choi CU, Kim SH, Kim JW, et al. Interatrial septal thickness as a marker of structural and functional remodeling of the left atrium in patients with atrial fibrillation. Korean J Intern Med. 2015;30:808–20.CrossRefGoogle Scholar
  15. 15.
    Ezhumalai B, Satheesh S, Anantha A, Pakkirisamy G, Balachander J, Selvaraj RJ. Coronary sinus diameter by echocardiography to differentiate atrioventricular nodal reentrant tachycardia from atrioventricular reentrant tachycardia. Cardiol J. 2014;21:273–8.CrossRefGoogle Scholar
  16. 16.
    Canpolat U, Aytemir K, Yorgun H, Asil S, Dural M, Özer N. The impact of echocardiographic Epicardial fat thickness on outcomes of cryoballoon-based atrial fibrillation ablation. Echocardiography. 2016;33:821–9.CrossRefGoogle Scholar
  17. 17.
    Allessie MA, de Groot NM, Houben RP, Schotten U, Boersma E, Smeets JL, et al. Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol. 2010;3:606–15.CrossRefGoogle Scholar
  18. 18.
    Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949–53.CrossRefGoogle Scholar
  19. 19.
    Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837–47.CrossRefGoogle Scholar
  20. 20.
    Akkaya E, Berkowitsch A, Zaltsberg S, Greiss H, Hamm CW, Sperzel J, et al. Second-generation cryoballoon ablation as a first-line treatment of symptomatic atrial fibrillation: two-year outcome and predictors of recurrence after a single procedure. Int J Cardiol. 2018;259:76–81.CrossRefGoogle Scholar
  21. 21.
    Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460–6.CrossRefGoogle Scholar
  22. 22.
    Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK, et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J. 2007;71:536–9.CrossRefGoogle Scholar
  23. 23.
    Chen PS, Turker I. Epicardial adipose tissue and neural mechanisms of atrial fibrillation. Circ Arrhythm Electrophysiol. 2012;5:618–20.CrossRefGoogle Scholar
  24. 24.
    Tsao HM, Hu WC, Wu MH, Tai CT, Lin YJ, Chang SL, et al. Quantitative analysis of quantity and distribution of epicardial adipose tissue surrounding the left atrium in patients with atrial fibrillation and effect of recurrence after ablation. Am J Cardiol. 2011;107:1498–503.CrossRefGoogle Scholar
  25. 25.
    Nagashima K, Okumura Y, Watanabe I, Nakai T, Ohkubo K, Kofune T, et al. Association between epicardial adipose tissue volumes on 3-dimensional reconstructed CT images and recurrence of atrial fibrillation after catheter ablation. Circ J. 2011;75:2559–65.CrossRefGoogle Scholar
  26. 26.
    Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G, et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57:1745–51.CrossRefGoogle Scholar
  27. 27.
    Savelieva I, Camm AJ. Upstream therapies after pulmonary vein ablation: five negative studies–what’s next? Europace. 2010;12:1509–13.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Hasan Koca
    • 1
  • Abdullah Orhan Demirtas
    • 1
  • Onur Kaypaklı
    • 2
  • Yahya Kemal Icen
    • 1
  • Durmus Yıldıray Sahin
    • 1
  • Fadime Koca
    • 1
  • Zikret Koseoglu
    • 3
  • Ahmet Oytun Baykan
    • 4
  • Emel Celiker Guler
    • 1
  • Derya Demirtas
    • 5
  • Mevlut Koc
    • 1
    Email author
  1. 1.Department of CardiologyUniversity of Health Sciences - Adana Health Practice and Research CenterAdanaTurkey
  2. 2.Department of Cardiology, Faculty of MedicineMustafa Kemal UniversityAntakyaTurkey
  3. 3.Department of Emergency MedicineUniversity of Health Sciences - Adana Health Practice and Research CenterAdanaTurkey
  4. 4.Department of CardiologyOrtadogu Adana HospitalAdanaTurkey
  5. 5.Department of Internal MedicineUniversity of Health Sciences - Adana Health Practice and Research CenterAdanaTurkey

Personalised recommendations